TrialBlood advances2024

Magrolimab plus rituximab with or without chemotherapy in patients with relapsed/refractory diffuse large B-cell lymphoma.

Joseph E Maakaron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.